HBI Deals+Insights / M&A/IPOs

Meinian looks beyond iKang

Chinese outpatient and health check-up group, Meinian Onehealth, has purchased a controlling stake in rival, Ciming Health. Meinian is paying 2.7bn Yuan (US$413m) for 72.22% and will raise 1.9bn Yuan (US$291m) worth of funding through a private placement. The deal suggests Meinian has given up on the takeover of rival, iKang, which is currently pursuing a lawsuit for information theft.

We would welcome your thoughts on this story. Email your views to Max Hotopf or call 0207 183 3779.